IMC-F106C
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMC-F106C, covering 2026-02-25 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors [Phase 1, Phase 2]